发明名称 SPIROCYCLIC INHIBITORS OF METALLOPROTEASES
摘要 FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention relates to novel spiroketals of the formula (I): where A2 is phenyl, substituted phenyl where substituents are represented by: alkyl, alkoxyalkyl, phenoxy-group, halogen atom, pyridyloxy-group, alkoxy- alkoxy-group, halogenphenoxy-group; R1 is hydrogen atom; R2 is hydrogen atom, C1-C4-alkyl; W represents oxygen atom or one or some C1-C4-alkyl fragments; Y means independently one or some members of group consisting of H2, -SR3, alkoxy-group; R3 is hydrogen atom; Z is carbocyclic or heterocyclic spiro-fragment with 3-7 members of ring system where heterocyclic fragment involves 2 oxygen or sulfur atoms, or one nitrogen atom being spiro-cycle can be unsubstituted or substituted with hydroxy-group, C1-C4-alkyl, benzyloxy-group; n = 1-3; optical isomers, diastereomers or enantiomers or their pharmaceutically acceptable salts. Compounds of the formula (I) inhibit activity of metalloprotease that ensures to use their in pharmaceutical composition for treatment or prophylaxis of disease associated with enhanced activity of metalloprotease. EFFECT: valuable medicinal properties of compounds. 10 cl, 5 tbl
申请公布号 RU2203274(C2) 申请公布日期 2003.04.27
申请号 RU19990106587 申请日期 1997.08.22
申请人 DZE PROKTER EHND GEHMBL KOMPANI 发明人 VANG ZKHE;ALMSTED NEJL GREGORI;BREHDLI RIMMA SANDLER;NEHTCHAS MAJKL DZHORDZH;DE BISVANATKH;PIKUL STANISLAV;TAJVO JETUNDE OLABISI
分类号 C07D487/10;A61K31/40;A61K31/403;A61K31/407;A61K31/435;A61K31/438;A61K31/527;A61P1/02;A61P1/04;A61P3/00;A61P3/04;A61P3/10;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P13/12;A61P15/06;A61P15/08;A61P15/18;A61P17/00;A61P17/02;A61P17/06;A61P17/14;A61P19/02;A61P19/04;A61P21/00;A61P25/28;A61P27/02;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/12;A61P31/18;A61P31/22;A61P33/02;A61P33/06;A61P35/00;A61P35/02;A61P37/06;A61P37/08;A61P39/02;A61P41/00;A61P43/00;C07D207/48;C07D209/54;C07D209/96;C07D471/10;C07D491/10;C07D491/113;C07D491/20;C07D493/20;C07D495/10 主分类号 C07D487/10
代理机构 代理人
主权项
地址